Fluence has already exceeded its full-year 2025 EBITDA after nine months of 2026, but delayed customer decisions have cut order intake and pushed operating cash flow into the red. The ASX-listed water treatment group is betting on a stronger fourth quarter to convert its improving margins into cash and backlog.
